XBiotech Inc. (XBIT) stock
XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.78−0.07 (-3.78%)
Close on Nov 17, 2026Market cap $54.27MP/E –Yield –
XBiotech profit margin
Profit margin (net margin) is net income as a percentage of revenue.
XBiotech's profit margin for the twelve months ending Sep 30, 2023 was -7708.3%. For fiscal 2022 it was -820.4%, against -94.7% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -820.4% | −725.8 |
| FY2021 | Dec 31, 2021 | -94.7% | −69.2 |
| FY2020 | Dec 31, 2020 | -25.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | -1067.7% | −924.0 |
| Q3 FY2022 | Sep 30, 2022 | -753.5% | −681.3 |
| Q2 FY2022 | Jun 30, 2022 | -761.0% | −647.9 |
| Q1 FY2022 | Mar 31, 2022 | -1079.0% | −1026.1 |
| Q4 FY2021 | Dec 31, 2021 | -143.7% | −108.8 |
| Q3 FY2021 | Sep 30, 2021 | -72.2% | −48.2 |
| Q2 FY2021 | Jun 30, 2021 | -113.1% | −68.9 |
| Q1 FY2021 | Mar 31, 2021 | -52.9% | −52.8 |
| Q4 FY2020 | Dec 31, 2020 | -34.9% | – |
| Q3 FY2020 | Sep 30, 2020 | -23.9% | – |
| Q2 FY2020 | Jun 30, 2020 | -44.2% | – |
| Q1 FY2020 | Mar 31, 2020 | -0.1% | – |
See a number that looks wrong?